ReviewFrontiers in oncology2024

Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma.

Issam S Hamadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.